Hemoglobin Predicts Mortality Risk in Geriatric Patients with Dysphagia: A Japanese Retrospective Cohort Study

Why It Matters

Hb provides a simple, inexpensive prognostic tool to stratify risk and guide nutritional interventions in frail older adults with dysphagia, a group with high mortality.

Key Takeaways

• Hemoglobin ≥12 g/dL cut mortality risk by 64% vs <9 g/dL
• Each 1 g/dL rise in Hb reduces death hazard by 17%
• Median survival extended from 185 to 405 days across Hb tertiles
• Association persists after adjusting for age, comorbidities, inflammation, nutrition
• Low-cost Hb test can guide nutritional and prognostic decisions

Pulse Analysis

Dysphagia affects up to one‑third of seniors and is linked to malnutrition, aspiration pneumonia, and sharply increased mortality. While clinicians routinely assess swallowing function, objective biomarkers that forecast outcomes have been scarce. Hemoglobin, a readily available indicator of oxygen‑carrying capacity and nutritional status, has emerged as a candidate, given its established ties to mortality in cardiovascular disease, cancer and chronic illness. In the context of geriatric dysphagia, low Hb often reflects anemia of chronic disease, iron deficiency, or bone‑marrow suppression, all of which can exacerbate frailty and impair recovery.

The Japanese cohort study examined 253 hospitalized elders requiring artificial nutrition and measured Hb within a week of PEG or TPN initiation. Using Cox proportional hazards models, the investigators demonstrated a dose‑response relationship: every 1 g/dL increase in Hb lowered the adjusted hazard of death by 17%, and patients with Hb ≥12 g/dL experienced a 64% reduction in mortality risk compared with those below 9 g/dL. Median survival more than doubled across tertiles, and the association held after controlling for age, sex, major comorbidities, inflammatory markers and caloric intake. Subgroup analyses showed no significant interactions, underscoring the robustness of Hb as an independent prognostic factor.

Clinically, these findings suggest that routine Hb monitoring could become a cornerstone of dysphagia management pathways, enabling early identification of high‑risk patients who may benefit from intensified nutritional support, anemia work‑up, or multidisciplinary rehabilitation. However, the single‑center, retrospective design limits generalizability, and the study captured only a baseline Hb value. Prospective, multicenter trials that track Hb trajectories and test targeted interventions are needed to confirm whether correcting anemia can translate into improved survival and quality of life for older adults with swallowing disorders.